JAMES C BLAIR Insider Trading Transactions
Get free email notifications about insider trading for JAMES C BLAIR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES C BLAIR. JAMES C BLAIR is 10% Owner in SENOMYX INC ($SNMX) and 10% Owner in INTRALASE CORP ($ILSE) and 10% Owner in Paratek Pharmaceuticals, Inc. ($PRTK) and Director in Paratek Pharmaceuticals, Inc. ($PRTK) and Director in PHARMION CORP ($PHRM) and 10% Owner in SANTARUS INC ($SNTS) and Director in NUVASIVE INC ($NUVA) and 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in Ocera Therapeutics, Inc. ($TZYM) and 10% Owner in Northstar Neuroscience, Inc. ($NSTR) and 10% Owner in ACHILLION PHARMACEUTICALS INC ($ACHN) and 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in Tobira Therapeutics, Inc. ($TBRA) and Director in CADENCE PHARMACEUTICALS INC ($CADX) and 10% Owner in SENORX INC ($SENO) and Director in aTYR PHARMA INC ($LIFE) and 10% Owner in Pernix Sleep, Inc. ($SOMX) and 10% Owner in INTERCELL USA, INC. ($IOMI) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in Volcano Corp ($VOLC) and Director in Volcano Corp ($VOLC) and Director in ZOGENIX, INC. ($ZGNX) and 10% Owner in VERACYTE, INC. ($VCYT) and 10% Owner in Orexigen Therapeutics, Inc. ($OREX) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in Evoke Pharma Inc ($EVOK) and 10% Owner in Esperion Therapeutics, Inc. ($ESPR) and 10% Owner in TANDEM DIABETES CARE INC ($TNDM) and Director in Clovis Oncology, Inc. ($CLVS) and 10% Owner in REVA Medical, Inc. ($RVA) and 10% Owner in Durata Therapeutics, Inc. ($DRTX).
Latest Insider Trading Transactions of JAMES C BLAIR
Sentiment: All, AKAO, ACHN, ALIM, LIFE, CADX, CLVS, DRNA, DRTX, ESPR, EVOK, IOMI, ILSE, NSTR, NUVA, TZYM, OREX, PRTK, SOMX, PHRM, RVA, SNTS, SNMX, SENO, TNDM, TBRA, VNDA, VCYT, VOLC, ZGNX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | C | 0.00 | 6,324 | 0 | 35,388 | 29.1 K to 35.4 K (+21.76 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | C | 0.00 | 15,106 | 0 | 29,064 | 14 K to 29.1 K (+108.22 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | C | 0.00 | 6,979 | 0 | 13,958 | 7 K to 14 K (+100.00 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | C | 0.00 | 6,979 | 0 | 6,979 | 0 to 7 K |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | P | 13.00 | 916,058 | 11,908,754 | 2,990,937 | 2.1 M to 3 M (+44.15 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | C | 0.00 | 370,799 | 0 | 2,074,879 | 1.7 M to 2.1 M (+21.76 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | C | 0.00 | 885,696 | 0 | 1,704,080 | 818.4 K to 1.7 M (+108.22 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | C | 0.00 | 409,192 | 0 | 818,384 | 409.2 K to 818.4 K (+100.00 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | C | 0.00 | 409,192 | 0 | 409,192 | 0 to 409.2 K |
Sep 20 2011 | ZGNX | ZOGENIX, INC. | BLAIR JAMES C | Director | Buy | P | 2.00 | 58,696 | 117,392 | 169,251 | 110.6 K to 169.3 K (+53.09 %) |
Sep 20 2011 | ZGNX | ZOGENIX, INC. | BLAIR JAMES C | Director | Buy | P | 2.00 | 3,441,304 | 6,882,608 | 9,923,335 | 6.5 M to 9.9 M (+53.09 %) |
May 26 2011 | ZGNX | ZOGENIX, INC. | BLAIR JAMES C | Director | Option Exercise | A | 3.87 | 12,500 | 48,375 | 12,500 | |
Jun 17 2011 | CADX | CADENCE PHARMACEUT ... | BLAIR JAMES C | Director | Option Exercise | A | 9.25 | 12,500 | 115,625 | 12,500 | |
Jun 03 2011 | ALIM | ALIMERA SCIENCES I ... | BLAIR JAMES C | 10% Owner | Sell | S | 8.04 | 6,914 | 55,589 | 40,790 | 47.7 K to 40.8 K (-14.49 %) |
Jun 03 2011 | ALIM | ALIMERA SCIENCES I ... | BLAIR JAMES C | 10% Owner | Buy | J | 0.00 | 18,864 | 0 | 18,864 | 0 to 18.9 K |
Jun 03 2011 | ALIM | ALIMERA SCIENCES I ... | BLAIR JAMES C | 10% Owner | Sell | J | 0.00 | 700,000 | 0 | 4,129,773 | 4.8 M to 4.1 M (-14.49 %) |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | BLAIR JAMES C | Director | Option Exercise | C | 0.00 | 106 | 0 | 0 | |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | BLAIR JAMES C | Director | Option Exercise | C | 0.00 | 9,894 | 0 | 0 | |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | BLAIR JAMES C | Director | Option Exercise | C | 0.00 | 14,903 | 0 | 0 | |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | BLAIR JAMES C | Director | Option Exercise | C | 0.00 | 21,027 | 0 | 0 | |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | BLAIR JAMES C | Director | Option Exercise | C | 0.00 | 35,215 | 0 | 0 | |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | BLAIR JAMES C | Director | Option Exercise | C | 0.00 | 873,800 | 0 | 0 | |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | BLAIR JAMES C | Director | Option Exercise | C | 0.00 | 1,232,861 | 0 | 0 | |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | BLAIR JAMES C | Director | Option Exercise | C | 0.00 | 2,064,781 | 0 | 0 | |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | BLAIR JAMES C | Director | Buy | C | 0.00 | 106 | 0 | 106 | 0 to 106 |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | BLAIR JAMES C | Director | Buy | C | 0.00 | 9,894 | 0 | 9,894 | 0 to 9.9 K |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | BLAIR JAMES C | Director | Buy | P | 4.00 | 39,410 | 157,640 | 110,555 | 71.1 K to 110.6 K (+55.39 %) |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | BLAIR JAMES C | Director | Buy | C | 0.00 | 14,903 | 0 | 71,145 | 56.2 K to 71.1 K (+26.50 %) |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | BLAIR JAMES C | Director | Buy | C | 0.00 | 21,027 | 0 | 56,242 | 35.2 K to 56.2 K (+59.71 %) |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | BLAIR JAMES C | Director | Buy | C | 0.00 | 35,215 | 0 | 35,215 | 0 to 35.2 K |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | BLAIR JAMES C | Director | Buy | P | 4.00 | 2,310,589 | 9,242,356 | 6,482,031 | 4.2 M to 6.5 M (+55.39 %) |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | BLAIR JAMES C | Director | Buy | C | 0.00 | 873,800 | 0 | 4,171,442 | 3.3 M to 4.2 M (+26.50 %) |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | BLAIR JAMES C | Director | Buy | C | 0.00 | 1,232,861 | 0 | 3,297,642 | 2.1 M to 3.3 M (+59.71 %) |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | BLAIR JAMES C | Director | Buy | C | 0.00 | 2,064,781 | 0 | 2,064,781 | 0 to 2.1 M |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Option Exercise | X | 6.51 | 2,930 | 19,064 | 0 | |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 1,152 | 0 | 0 | |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Option Exercise | J | 0.00 | 1,152 | 0 | 1,152 | |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Option Exercise | X | 6.51 | 2,837 | 18,459 | 0 | |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 358 | 0 | 0 | |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Option Exercise | J | 0.00 | 358 | 0 | 358 | |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Option Exercise | X | 3.28 | 510 | 1,673 | 0 | |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 858 | 0 | 0 | |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Option Exercise | J | 0.00 | 858 | 0 | 858 | |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Option Exercise | X | 6.04 | 1,911 | 11,539 | 0 | |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 14,652 | 0 | 0 | |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 56,563 | 0 | 0 | |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Option Exercise | X | 6.51 | 124,051 | 807,150 | 0 | |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 48,767 | 0 | 0 | |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Option Exercise | J | 0.00 | 48,767 | 0 | 48,767 | |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Option Exercise | X | 6.51 | 120,115 | 781,540 | 0 | |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 15,128 | 0 | 0 | |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Option Exercise | J | 0.00 | 15,128 | 0 | 15,128 | |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Option Exercise | X | 3.28 | 21,593 | 70,825 | 0 | |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 36,302 | 0 | 0 | |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Option Exercise | J | 0.00 | 36,302 | 0 | 36,302 | |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Option Exercise | X | 6.04 | 80,894 | 488,462 | 0 | |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 620,256 | 0 | 0 | |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 2,394,417 | 0 | 0 | |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Buy | J | 6.50 | 2,943 | 19,143 | 124,322 | 121.4 K to 124.3 K (+2.42 %) |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Buy | X | 3.28 | 46,606 | 152,868 | 121,379 | 74.8 K to 121.4 K (+62.33 %) |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Buy | X | 6.51 | 1,190 | 7,743 | 74,773 | 73.6 K to 74.8 K (+1.62 %) |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 1,152 | 0 | 73,583 | 72.4 K to 73.6 K (+1.59 %) |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 358 | 0 | 72,431 | 72.1 K to 72.4 K (+0.50 %) |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 858 | 0 | 72,073 | 71.2 K to 72.1 K (+1.20 %) |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 14,652 | 0 | 71,215 | 56.6 K to 71.2 K (+25.90 %) |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 56,563 | 0 | 56,563 | 0 to 56.6 K |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Buy | J | 6.51 | 124,544 | 810,358 | 5,262,583 | 5.1 M to 5.3 M (+2.42 %) |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Buy | X | 3.28 | 1,972,804 | 6,470,797 | 5,138,039 | 3.2 M to 5.1 M (+62.33 %) |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Buy | X | 6.51 | 50,365 | 327,705 | 3,165,235 | 3.1 M to 3.2 M (+1.62 %) |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 48,767 | 0 | 3,114,870 | 3.1 M to 3.1 M (+1.59 %) |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 15,128 | 0 | 3,066,103 | 3.1 M to 3.1 M (+0.50 %) |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 36,302 | 0 | 3,050,975 | 3 M to 3.1 M (+1.20 %) |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 620,256 | 0 | 3,014,673 | 2.4 M to 3 M (+25.90 %) |
Dec 20 2010 | RVA | REVA Medical, Inc. | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 2,394,417 | 0 | 2,394,417 | 0 to 2.4 M |
Oct 08 2010 | ACHN | ACHILLION PHARMACE ... | BLAIR JAMES C | 10% Owner | Buy | J | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Jun 17 2010 | CADX | CADENCE PHARMACEUT ... | BLAIR JAMES C | Director | Option Exercise | A | 7.16 | 12,500 | 89,500 | 12,500 | |
Apr 27 2010 | ALIM | ALIMERA SCIENCES I ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 6,091 | 0 | 0 | |
Apr 27 2010 | ALIM | ALIMERA SCIENCES I ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 12,233 | 0 | 0 | |
Apr 27 2010 | ALIM | ALIMERA SCIENCES I ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 11,894 | 0 | 0 | |
Apr 27 2010 | ALIM | ALIMERA SCIENCES I ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 17,486 | 0 | 0 | |
Apr 27 2010 | ALIM | ALIMERA SCIENCES I ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 568,423 | 0 | 0 | |
Apr 27 2010 | ALIM | ALIMERA SCIENCES I ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 1,141,486 | 0 | 0 | |
Apr 27 2010 | ALIM | ALIMERA SCIENCES I ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 1,109,970 | 0 | 0 | |
Apr 27 2010 | ALIM | ALIMERA SCIENCES I ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 1,631,866 | 0 | 0 | |
Apr 27 2010 | ALIM | ALIMERA SCIENCES I ... | BLAIR JAMES C | 10% Owner | Buy | P | 11.00 | 378,028 | 4,158,308 | 4,829,773 | 4.5 M to 4.8 M (+8.49 %) |
Apr 27 2010 | ALIM | ALIMERA SCIENCES I ... | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 47,704 | 0 | 47,704 | 0 to 47.7 K |
Apr 27 2010 | ALIM | ALIMERA SCIENCES I ... | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 4,451,745 | 0 | 4,451,745 | 0 to 4.5 M |
Dec 21 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 7.50 | 639 | 4,793 | 42,761 | 42.1 K to 42.8 K (+1.52 %) |
Dec 21 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 7.50 | 37,461 | 280,958 | 2,506,150 | 2.5 M to 2.5 M (+1.52 %) |
Dec 21 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 7.55 | 1,677 | 12,661 | 42,122 | 40.4 K to 42.1 K (+4.15 %) |
Dec 21 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 7.55 | 98,323 | 742,339 | 2,468,689 | 2.4 M to 2.5 M (+4.15 %) |
Nov 25 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 6.75 | 839 | 5,663 | 40,445 | 39.6 K to 40.4 K (+2.12 %) |
Nov 25 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 6.75 | 49,161 | 331,837 | 2,370,366 | 2.3 M to 2.4 M (+2.12 %) |
Nov 24 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 6.93 | 2,516 | 17,436 | 39,606 | 37.1 K to 39.6 K (+6.78 %) |
Nov 24 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 6.93 | 147,484 | 1,022,064 | 2,321,205 | 2.2 M to 2.3 M (+6.78 %) |
Nov 24 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 6.93 | 4,192 | 29,051 | 37,090 | 32.9 K to 37.1 K (+12.74 %) |
Nov 24 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 6.93 | 245,808 | 1,703,449 | 2,173,721 | 1.9 M to 2.2 M (+12.75 %) |
Nov 16 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 6.90 | 1,040 | 7,176 | 32,898 | 31.9 K to 32.9 K (+3.26 %) |
Nov 16 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 6.90 | 60,960 | 420,624 | 1,927,913 | 1.9 M to 1.9 M (+3.27 %) |
Nov 12 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 6.93 | 899 | 6,230 | 31,858 | 31 K to 31.9 K (+2.90 %) |
Nov 12 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 6.93 | 52,701 | 365,218 | 1,866,953 | 1.8 M to 1.9 M (+2.90 %) |
Nov 12 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 6.93 | 1,415 | 9,806 | 30,959 | 29.5 K to 31 K (+4.79 %) |
Nov 12 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 6.93 | 82,985 | 575,086 | 1,814,252 | 1.7 M to 1.8 M (+4.79 %) |
Aug 19 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 7.73 | 231 | 1,786 | 29,544 | 29.3 K to 29.5 K (+0.79 %) |
Aug 19 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 7.73 | 13,553 | 104,765 | 1,731,267 | 1.7 M to 1.7 M (+0.79 %) |
Aug 18 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 7.64 | 1,060 | 8,098 | 29,313 | 28.3 K to 29.3 K (+3.75 %) |
Aug 18 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 7.64 | 62,141 | 474,757 | 1,717,714 | 1.7 M to 1.7 M (+3.75 %) |
Aug 18 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 8.00 | 440 | 3,520 | 28,253 | 27.8 K to 28.3 K (+1.58 %) |
Aug 18 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 8.00 | 25,785 | 206,280 | 1,655,573 | 1.6 M to 1.7 M (+1.58 %) |
Aug 14 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 7.85 | 218 | 1,711 | 27,813 | 27.6 K to 27.8 K (+0.79 %) |
Aug 14 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 7.85 | 12,782 | 100,339 | 1,629,788 | 1.6 M to 1.6 M (+0.79 %) |
Aug 14 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 8.00 | 6,708 | 53,664 | 27,595 | 20.9 K to 27.6 K (+32.12 %) |
Aug 14 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 8.00 | 393,292 | 3,146,336 | 1,617,006 | 1.2 M to 1.6 M (+32.14 %) |
Aug 13 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 7.60 | 1,749 | 13,292 | 20,887 | 19.1 K to 20.9 K (+9.14 %) |
Aug 13 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 7.60 | 102,551 | 779,388 | 1,223,714 | 1.1 M to 1.2 M (+9.15 %) |
Jul 24 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 7.50 | 10,901 | 81,758 | 19,138 | 8.2 K to 19.1 K (+132.34 %) |
Jul 24 2009 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 7.50 | 639,099 | 4,793,243 | 1,121,163 | 482.1 K to 1.1 M (+132.58 %) |
Jun 25 2009 | CADX | CADENCE PHARMACEUT ... | BLAIR JAMES C | Director | Option Exercise | A | 9.37 | 12,500 | 117,125 | 12,500 | |
Jan 30 2009 | PRTK | Paratek Pharmaceut ... | BLAIR JAMES C | 10% Owner | Sell | S | 0.98 | 3,427 | 3,358 | 67,875 | 71.3 K to 67.9 K (-4.81 %) |
Jan 30 2009 | PRTK | Paratek Pharmaceut ... | BLAIR JAMES C | 10% Owner | Sell | S | 0.98 | 146,873 | 143,936 | 2,907,523 | 3.1 M to 2.9 M (-4.81 %) |
Jan 30 2009 | PRTK | Paratek Pharmaceut ... | BLAIR JAMES C | 10% Owner | Sell | S | 0.91 | 1,436 | 1,307 | 71,302 | 72.7 K to 71.3 K (-1.97 %) |
Jan 30 2009 | PRTK | Paratek Pharmaceut ... | BLAIR JAMES C | 10% Owner | Sell | S | 0.91 | 61,564 | 56,023 | 3,054,396 | 3.1 M to 3.1 M (-1.98 %) |
Jan 30 2009 | PRTK | Paratek Pharmaceut ... | BLAIR JAMES C | 10% Owner | Sell | S | 0.93 | 837 | 778 | 72,738 | 73.6 K to 72.7 K (-1.14 %) |
Jan 30 2009 | PRTK | Paratek Pharmaceut ... | BLAIR JAMES C | 10% Owner | Sell | S | 0.93 | 35,863 | 33,353 | 3,115,960 | 3.2 M to 3.1 M (-1.14 %) |
Feb 20 2009 | CADX | CADENCE PHARMACEUT ... | BLAIR JAMES C | Director | Option Exercise | P | 7.84 | 23,317 | 182,805 | 23,317 | |
Feb 20 2009 | CADX | CADENCE PHARMACEUT ... | BLAIR JAMES C | Director | Option Exercise | P | 7.84 | 1,367,020 | 10,717,437 | 1,367,020 | |
Feb 20 2009 | CADX | CADENCE PHARMACEUT ... | BLAIR JAMES C | Director | Buy | P | 7.13 | 46,634 | 332,500 | 46,634 | 0 to 46.6 K |
Feb 20 2009 | CADX | CADENCE PHARMACEUT ... | BLAIR JAMES C | Director | Buy | P | 7.13 | 2,734,040 | 19,493,705 | 2,734,040 | 0 to 2.7 M |
Dec 10 2008 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 4.93 | 4,064 | 20,036 | 8,237 | 4.2 K to 8.2 K (+97.39 %) |
Dec 10 2008 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 4.93 | 237,826 | 1,172,482 | 482,064 | 244.2 K to 482.1 K (+97.37 %) |
Dec 10 2008 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 4.47 | 4,173 | 18,653 | 4,173 | 0 to 4.2 K |
Dec 10 2008 | OREX | Orexigen Therapeut ... | BLAIR JAMES C | 10% Owner | Buy | P | 4.47 | 244,238 | 1,091,744 | 244,238 | 0 to 244.2 K |
Jul 18 2008 | VOLC | Volcano Corp | BLAIR JAMES C | 10% Owner | Sell | S | 14.49 | 15,655 | 226,841 | 62,513 | 78.2 K to 62.5 K (-20.03 %) |
Jul 18 2008 | VOLC | Volcano Corp | BLAIR JAMES C | 10% Owner | Sell | S | 14.49 | 3,702 | 53,642 | 14,782 | 18.5 K to 14.8 K (-20.03 %) |
Jul 18 2008 | VOLC | Volcano Corp | BLAIR JAMES C | 10% Owner | Sell | J | 0.00 | 662,711 | 0 | 2,646,328 | 3.3 M to 2.6 M (-20.03 %) |
Jul 18 2008 | VOLC | Volcano Corp | BLAIR JAMES C | 10% Owner | Sell | J | 0.00 | 467,932 | 0 | 1,868,540 | 2.3 M to 1.9 M (-20.03 %) |
Jun 09 2008 | VOLC | Volcano Corp | BLAIR JAMES C | Director | Buy | J | 0.00 | 1,480 | 0 | 56,718 | 55.2 K to 56.7 K (+2.68 %) |
Jun 09 2008 | VOLC | Volcano Corp | BLAIR JAMES C | Director | Buy | J | 0.00 | 29,581 | 0 | 70,916 | 41.3 K to 70.9 K (+71.56 %) |
Apr 10 2008 | VOLC | Volcano Corp | BLAIR JAMES C | Director | Sell | S | 12.98 | 13,613 | 176,697 | 78,168 | 91.8 K to 78.2 K (-14.83 %) |
Apr 10 2008 | VOLC | Volcano Corp | BLAIR JAMES C | Director | Sell | S | 12.98 | 3,219 | 41,783 | 18,484 | 21.7 K to 18.5 K (-14.83 %) |
Apr 10 2008 | VOLC | Volcano Corp | BLAIR JAMES C | Director | Sell | J | 0.00 | 576,270 | 0 | 3,309,039 | 3.9 M to 3.3 M (-14.83 %) |
Apr 10 2008 | VOLC | Volcano Corp | BLAIR JAMES C | Director | Sell | J | 0.00 | 406,898 | 0 | 2,336,472 | 2.7 M to 2.3 M (-14.83 %) |
Jun 19 2008 | CADX | CADENCE PHARMACEUT ... | BLAIR JAMES C | Director | Option Exercise | A | 6.35 | 12,500 | 79,375 | 12,500 | |
Mar 19 2008 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Option Exercise | D | 31.27 | 7,500 | 234,525 | 0 | |
Mar 19 2008 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Option Exercise | D | 18.65 | 7,500 | 139,875 | 0 | |
Mar 19 2008 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Option Exercise | D | 20.33 | 5,000 | 101,650 | 0 | |
Mar 19 2008 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Option Exercise | D | 38.98 | 5,000 | 194,900 | 0 | |
Mar 19 2008 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Sell | J | 0.00 | 25,066 | 0 | 0 | 25.1 K to 0 (-100.00 %) |
Mar 19 2008 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Sell | J | 0.00 | 1,206 | 0 | 0 | 1.2 K to 0 (-100.00 %) |
Mar 19 2008 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Sell | J | 0.00 | 15,900 | 0 | 0 | 15.9 K to 0 (-100.00 %) |